The role of resveratrol on rheumatoid arthritis: From bench to bedside
Open Access
- 22 August 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 829677
Abstract
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by symmetrical polyarthritis as its main clinical manifestation. Uncontrolled RA eventually leads to joint deformities and loss of function. Currently, the pathogenesis of RA remains under discussion, and RA treatment is still at the bottleneck stage. Resveratrol has long been regarded as a potential antioxidant drug for RA treatment. Currently, resveratrol is considered to exert therapeutic effects on RA by activating silent information regulator 1 (SIRT1) and its downstream pathways. There is notable crosstalk between the SIRT1 and NF-κB pathways, and these pathways, which play an essential role in the development of RA, are unexpectedly linked to the influence of resveratrol. Based on recent studies of almost all the pathways that resveratrol can affect, this review summarizes a regulatory chain of core components that cover multiple tracks. We also list the effects of resveratrol on immune cells and other subtle controls, which can help clinicians understand the known mechanism of resveratrol and better treat patients with RA.Keywords
This publication has 95 references indexed in Scilit:
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial FunctionCell Metabolism, 2012
- The Pathogenesis of Rheumatoid ArthritisNew England Journal of Medicine, 2011
- The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseasesArthritis & Rheumatism, 2010
- Resveratrol induces apoptosis MH7A human rheumatoid arthritis synovial cells in a sirtuin 1-dependent mannerRheumatology International, 2010
- Resveratrol: Biological and pharmaceutical properties as anticancer moleculeBioFactors, 2010
- Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritisArthritis & Rheumatism, 2009
- The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registryRheumatology, 2008
- Bradykinin stimulates c-fos expression, AP-1-DNA binding activity and proliferation of rat glomerular mesangial cellsKidney International, 1996
- KININS—KEY MEDIATORS IN INFLAMMATORY ARTHRITIS?Rheumatology, 1992
- Rheumatoid ArthritisNew England Journal of Medicine, 1990